Intron A

In the US, Intron A (interferon alfa-2b systemic) is a member of the drug class antineoplastic interferons and is used to treat Angioblastoma, Condylomata Acuminata, Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hepatitis B, Hepatitis C, Idiopathic Thrombocytopenic Purpura, Kaposi's Sarcoma and Melanoma.

US matches:

• Intron A

Ingredient matches for Intron A

Interferon alfa

Interferon alfa Interferon alfa-2b (Arg-23; His-34) (a derivative of Interferon alfa) is reported as an ingredient of Intron A in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Brazil


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Egypt


• El Salvador


• Georgia


• Germany


• Guatemala


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Iran


• Iraq


• Israel


• Japan


• Jordan


• Kenya


• Kuwait


• Lebanon


• Luxembourg


• Mexico


• Netherlands


• Nicaragua


• Norway


• Oman


• Panama


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Switzerland


• Syria


• Thailand


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Venezuela


• Yemen

International Drug Name Search